Sleep Disorders Pharmaceutical and Healthcare Pipeline Review 2017

Pune, India, 13th October 2017: WiseGuyReports announced addition of new report, titled “Sleep Disorders Drug Development Pipeline Review, 2017”.

Pune, India - October 13, 2017 /MarketersMedia/ —

Summary
This report provides an overview of the pipeline landscape for sleep disorders. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for Restless Legs Syndrome, Nocturia and Insomnia, and features dormant and discontinued projects.

Restless Legs Syndrome is a neurologic disorder with a core feature of a distressing, irresistible need or urge to move the legs. Risk factors for RLS include low iron levels, kidney failure, Parkinson's disease, diabetes mellitus, rheumatoid arthritis, and pregnancy.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/2385279-sleep-disorders-drug-development-pipeline-review-2017

Nocturia, or nocturnal polyuria, describes the excessive urination during night time. Nocturia becomes more common with age and may be symptomatic of the use of diuretic substances, prescription drugs, edema from heart failure, insomnia, pain and prostate or bladder disorders.

Finally, insomnia is a sleep disorder that is characterized by difficulty in falling or staying asleep. Symptoms include difficulty falling asleep at night, waking up during the night, irritability, depression and anxiety.

The size of these pipelines ranges from eight products in restless legs syndrome and nocturia to 31 in insomnia. Across all three of these indications there is a diverse range of molecular targets due to the different pathologies of the indications. The most common targets for restless legs syndrome, nocturia and insomnia therapeutics are D2 dopamine receptor, vasopressin V2 receptor and orexin receptor, respectively.

Scope
- Which companies are the most active within the pipeline for sleep disorder therapeutics?
- Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
- To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
- What are the most important R&D milestones and data publications to have happened in the field of sleep disorders?

Reasons to buy
- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
- Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration

Table of Content: Key Points

1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 Sleep Disorders Report Coverage 7
2.2 Restless Legs Syndrome - Overview 7
2.3 Nocturia - Overview 7
2.4 Insomnia - Overview 7
3 Therapeutics Development 8
3.1 Restless Legs Syndrome 8
3.2 Nocturia 11
3.3 Insomnia 14
4 Therapeutics Assessment 21
4.1 Restless Legs Syndrome 21
4.2 Nocturia 27
4.3 Insomnia 33
5 Companies Involved in Therapeutics Development 39
5.1 Restless Legs Syndrome 39
5.2 Nocturia 42
5.3 Insomnia 44
6 Dormant Projects 53
6.1 Restless Legs Syndrome 53
6.2 Nocturia 53
6.3 Insomnia 54
7 Discontinued Products 56
7.1 Restless Legs Syndrome 56
7.2 Insomnia 56
8 Product Development Milestones 58
8.1 Restless Legs Syndrome 58
8.2 Nocturia 63
…Continued

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Contact Info:
Name: NORAH TRENT
Email: Send Email
Organization: WISEGUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers
Phone: +91 841 198 5042

Source URL: https://marketersmedia.com/sleep-disorders-pharmaceutical-and-healthcare-pipeline-review-2017/250082

For more information, please visit http://www.wiseguyreports.com

Source: MarketersMedia

Release ID: 250082

More News From 24-7reporters.com

Trump to call families of slain soldiers, questions Obama

Oct 17, 2017

WASHINGTON — President Donald Trump on Tuesday will call the families of four soldiers killed this month in Niger, the White House says, as Trump again casts doubt on whether his predecessor appropriately consoled the families of military personnel who died in war. Trump suggested Tuesday that President Barack Obama did not call John Kelly, a former Marine general who is now White House chief of staff, when his son, Marine 2nd Lt. Robert Kelly, was killed in Afghanistan in 2010. "I think I've called every family of someone who's died," Trump told Fox News radio. "As far as other...

Marino returns, 4 years after retiring because of depression

Oct 17, 2017

MONTREAL — Former top-50 tennis player Rebecca Marino will come out of retirement after more than 4½ years and enter a pair of tournaments. Tennis Canada announced Tuesday that the 26-year-old Marino will appear in events at Saguenay and Toronto. Marino left professional tennis in February 2013, and said she had been dealing with depression. She was ranked as high as No. 38 in 2011, when she was the runner-up at a tournament in Memphis and reached the third round of the French Open, her best Grand Slam showing. Marino says she started training in September and doesn't have "any...

Trump's wealth, ranking fall in latest Forbes 400 list

Oct 17, 2017

NEW YORK — President Donald Trump's ranking in the Forbes list of wealthiest Americans has dropped, as the magazine said the value of some of his Manhattan real estate holdings has declined recently. Forbes ranked the first billionaire president as the 248th-wealthiest person in America and put his wealth at $3.1 billion . The year before, he was ranked 156th and Forbes said he was worth $3.7 billion. As a candidate, Trump said his net worth was more than $10 billion, but Forbes pegged that figure at $4.5 billion in September 2015. By Forbes' estimates, Trump's wealth has fallen 31...

Roman Polanski in Poland for documentary on his early life

Oct 17, 2017

WARSAW, Poland — A Polish film company said Tuesday that Oscar-winning director Roman Polanski has traveled to Poland to appear in a documentary about his early life during the Holocaust and after the war in Poland. The KRK Film company said that Polanski was in Krakow to see the site of the former ghetto where he was held as a child by the German Nazis. His mother was taken from there to her death at Auschwitz, and later his father made him flee the ghetto. The 84-year-old director also visited the village of Wysoka, where he was in hiding after...

US military says IS 'capital' of Raqqa 90 percent freed

Oct 17, 2017

WASHINGTON — The U.S. military says the Syrian city of Raqqa is about 90 percent cleared of Islamic State fighters. After the U.S.-backed Syrian Democratic Forces announced that Raqqa was fully liberated on Tuesday, a spokesman for the coalition, Col. Ryan Dillon, told reporters at the Pentagon that more fighting remained. Dillion, speaking from his headquarters in Baghdad, said "pockets of resistance" can be expected as local Syrian Kurdish and Arab fighters allied with the U.S. coalition press ahead with clearing operations in the city. Dillon said that even after Raqqa is fully liberated, more fighting will be required to...

Weather, 20 December
Houston Weather
+7

High: +11° Low: -2°

Humidity: 83%

Wind: NNE - 7 KPH

Canberra Weather
+27

High: +27° Low: +17°

Humidity: 87%

Wind: W - 20 KPH

Roissy-en-France Weather
+6

High: +6° Low: -5°

Humidity: 87%

Wind: ENE - 7 KPH

Florence Weather
+9

High: +9° Low: +6°

Humidity: 97%

Wind: ENE - 17 KPH

Parga Weather
+7

High: +16° Low: +4°

Humidity: 100%

Wind: SE - 25 KPH

About Us

24-7 Reporters publishes up-to-the-minute news 24 hours a day, 7 days a week. Our certified reporters are among the most experienced, well-trained and talented across the globe, covering issues resonating progressives in every corner of the world.

Contact us: sales@reporterscom.com